Clinical Trials Logo

Filter by:
NCT ID: NCT05921695 Recruiting - Heat Stroke Clinical Trials

The Relationship Between Normal Saline Infusion and Acute Kidney Injury in Heat Stroke

Start date: May 28, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the effect of high chlorine solution such as normal saline and non-high chlorine solution such as sodium lactate ringer's solution on renal function in patients with heat stroke. The main question it aims to answer is whether limiting the amount of normal saline infusion during emergency department can lower the incidence of acute kidney injury and mortality in patients with heat stroke. Participants will receive a free normal saline infusion during the emergency department according to the study design, or a restricted normal saline infusion while using sodium lactate Ringer's instead. Researchers will compare the normal saline infusion group and sodium lactate Ringer's group to see if limiting the amount of normal saline infusion during emergency department can lower the incidence of acute kidney injury and mortality in patients with heat stroke.

NCT ID: NCT05921682 Recruiting - Heat Stroke Clinical Trials

Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke

Start date: May 28, 2023
Phase:
Study type: Observational

The goal of this observational study is to explore the optimal target body temperature in first 24 hours and the relationship between body temperature and adverse outcomes of heat stroke. The main questions it aims to answer are: - the optimal target body temperature at 0.5 h, 2 h, and the lowest body temperature of heat stroke. - the best body temperature at the cutting point of stop cooling. - The relationship between the volume and speed of ice saline infusion and the cooling effect.

NCT ID: NCT05921656 Completed - Clinical trials for Mechanical Ventilation

Construction and Evaluation of Airway Leakage Risk Model of Patients With Endotracheal Tube

Start date: September 30, 2021
Phase:
Study type: Observational

There are two cases in which the cross-sectional area of the tracheal catheter balloon does not match the cross-sectional area of the patient's airway. If the area of the tracheal catheter balloon is smaller than the cross-sectional area of the patient's airway, the pressure in the balloon reaches 30 cmH2O, and the airway cannot be completely sealed; This will increase the risk of VAP. If the area of the tracheal catheter balloon is significantly larger than the cross-sectional area of the patient's airway, and the pressure in the balloon reaches 30 cmH2O, the airway cannot be effectively sealed; The formation of wrinkles around the airbag also increases the risk of VAP in patients. Therefore, the purpose of this study is to build a risk model of airway leakage of patients' endotracheal tubes, which provides an accurate and objective assessment tool for medical staff, so that medical staff can select the endotracheal tubes purposefully and with emphasis from the beginning of the patients' endotracheal tubes, and reduce the airway leakage or airway mucosal damage of the endotracheal tubes.

NCT ID: NCT05921617 Recruiting - Clinical trials for Musculoskeletal Health

A Cohort Study of Musculoskeletal Health in Patients With Breast Cancer During Aromatase Inhibitors Therapy

Start date: April 27, 2023
Phase:
Study type: Observational

Postmenopausal women with hormone receptor-positive breast cancer are now prescribed aromatase inhibitors with 5 years or longer durations of therapy as recommended by clinical guidelines, which contributes to reducing breast cancer recurrence. However, aromatase inhibitors treatment is associated with a high incidence of musculoskeletal symptoms (MSS), often described as symmetrical pain, soreness in the joints, musculoskeletal pain, and joint stiffness, which even leads to bone loss, osteoporosis, and fractures. MSS reduces patients' quality of life and compliance with aromatase inhibitors therapy in up to one-half of women undergoing adjuvant aromatase inhibitors therapy, potentially compromising breast cancer outcomes. Therefore, this study aimed to monitor the musculoskeletal health of breast cancer patients during endocrine therapy to provide references for clinical practice.

NCT ID: NCT05921344 Not yet recruiting - Type 2 Diabetes Clinical Trials

Preclinical Research of mμSORS for Noninvasive Blood Glucose Detection

Start date: June 20, 2023
Phase: N/A
Study type: Interventional

This is a single-center, open-label, prospective study. Blood glucose was measured at different time points during oral glucose tolerance testing in patients with type 2 diabetes mellitus, using both venous plasma and multi-channel microspatial offset Raman scattering spectroscopy (mμSORS). Venous plasma glucose was set as gold standard.The two measurements were collected synchronously so as to calculate the mean absolute relative difference (MARD) and the consensus error grid (CEG). Accuracy of non-invasive blood glucose testing by mμSORS will be validated. MARD for two measurement methods in different blood glucose ranges and the safety outcomes of mμSORS such as adverse events will also be assessed.

NCT ID: NCT05921331 Not yet recruiting - Breast Cancer Clinical Trials

RJBC-APP and Breast Cancer Treatment Compliance

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The goal of this multicentric randomized controlled clinical trial is to test the role of mobile medical application (APP) on adjuvant therapy compliance and quality of life (QoL) in patients with early breast cancer. Participants assigned to the Ruijin Breast Cancer APP (RJBC-APP) group can receive treatment reminders, matters needing attention as well as science knowledge and they can communicate with the medical staff during adjuvant treatments while follow-up can only be conducted in outpatient clinic for those in the Control group.

NCT ID: NCT05921318 Recruiting - Clinical trials for Hematologic Malignancy

Beijing Protocol in Patients Receiving More Than 5/10 HLA-mismatched Allo-HSCT

Start date: June 1, 2023
Phase:
Study type: Observational [Patient Registry]

The aim of the study is to evaluate the efficacy and safety of Beijing protocol in malignant haematologic disease patients receiving more than 5/10 HLA-mismatched allo-HSCT.

NCT ID: NCT05921305 Recruiting - Clinical trials for Acute Graft Versus Host Disease

Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD

Start date: August 3, 2023
Phase: Phase 3
Study type: Interventional

This trial is a randomized (1:1) phase III open label study of frontline mini-MTX plus methylprednisolone 2mg/kg/day compared to methylprednisolone 2mg/kg in allogeneic stem cell transplant recipients with grade 2-4 aGVHD.

NCT ID: NCT05921084 Active, not recruiting - Stroke Clinical Trials

MIND Diet to Improve Cognitive Function in Mild Stroke Patients

MINDICOMS
Start date: July 23, 2023
Phase: N/A
Study type: Interventional

A 6-month pilot randomized controlled trial designed to test the effect of the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet + usual medical care versus usual medical care on the rate of cognitive change and several other secondary outcomes through a randomized controlled trial in 60 mild stroke patients aged 35-70 years without dementia.

NCT ID: NCT05921006 Recruiting - Drug Safety Clinical Trials

Ascending Single-Dose and Multiple-Dose Study to Evaluate RJ4287 in Healthy Subjects

Start date: June 13, 2023
Phase: Phase 1
Study type: Interventional

A Randomized Study of RJ4287 Drug to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-effect of Single and Multiple Doses in Healthy Volunteers